FundedIQ
Biotechnology

Kardigan: Funding, Investors & Team (Oct 2026)

Kardigan is a heart health company that is changing the way cardiovascular medications are developed by focusing on patient needs, aiming to create drugs that go beyond just managing symptoms to actually curing the condition.

www.kardigan.bio LinkedIn South San Francisco, United States 51-100 employees
Biopharma Health Care Medical
Total raised
$554M
Rounds
2
Latest
Series B
Oct 2025

Kardigan has raised $554M across 2 funding rounds on record, the most recent a Series B of $254M announced in Oct 2025.

That round is above the $8.4M median round size for Biotechnology companies tracked on FundedIQ over the last two years.

Kardigan Company Profile and Key Stats

Total funding raised
$554M
across 2 rounds on record
Funding rounds on record
2
Latest funding round
Series B
$254M in Oct 2025
Employees
51-100
reported band
Headquarters
South San Francisco, United States

Latest funding round on record: Oct 2025.

Kardigan Funding Rounds

Date
Round
Amount
Series B
$254M
Series A
$300M

Kardigan raised $300M in a Series A announced in Jan 2025.

9 months later, a Series B of $254M was announced in Oct 2025.

Kardigan Founders and Leadership Team

Name
Role
Contact
Bob Mcdowell
Founder
Locked
Jay Edelberg
Founder
—
Tassos Gianakakos
CEO
Locked

Contact details for the Kardigan team: 2 of 3 have an email address on file, 1 has a LinkedIn profile.

Start 14-day free trial →

Kardigan Funding Compared to Other Biotechnology Startups

Segment
Companies
Median round
4,185
$8.4M
30,319
$7.7M
4,422
$32M

Kardigan's latest round of $254M is above the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.

Funded Startups Like Kardigan in Biotechnology and South San Francisco

Companies Similar to Kardigan

Prolific Machines is a biotech company located in San Francisco, California, that was established in 2020. It…

Series B $50.0M

Altay Therapeutics is a biotech company focused on finding and discovering small molecule therapies for…

Series A $37.0M
Series B $150M

Kallyope, we believe that the gut is the gateway to our internal world. Containing millions of neurons, the…

Undisclosed round $94.0M

Astrocyte Pharmaceuticals is a drug development company that helps in the recovery and well-being of brain…

Series B $9.5M

Tiny Health offers a gut health test specifically designed for mothers and babies aged 0 to 3 years.…

Series B $33.0M

Junevity is dedicated to using cutting-edge transcription factor medicines to combat age-related diseases.…

Undisclosed round —

Arkea Bio creates technology aimed at reducing greenhouse gas (GHG) emissions in the agricultural sector.

Series A $15.0M

Serán is a contract development and manufacturing organization providing a comprehensive suite of…

Private Equity —

Precision’s goal is to provide breakthrough treatments for the one billion patients worldwide suffering from…

Series D $250M

Enveda is a biotechnology company that utilizes AI-powered tools to explore and characterize molecules from…

Series E $311M

Avery Therapeutics, Inc. is a company dedicated to developing tissue engineered therapeutics to treat…

Undisclosed round $8.5M

Kardigan Funding FAQs

What does Kardigan do?

Kardigan is a heart health company that is changing the way cardiovascular medications are developed by focusing on patient needs, aiming to create drugs that go beyond just managing symptoms to actually curing the condition.

How much funding has Kardigan raised?

Kardigan has raised $554M across 2 rounds on record. The most recent is a Series B of $254M announced in Oct 2025.

When did Kardigan last raise funding?

Kardigan's most recent funding round on record is a Series B of $254M, announced in Oct 2025.

Who founded Kardigan?

FundedIQ lists Bob Mcdowell (Founder), Jay Edelberg (Founder) at Kardigan.

Who is the CEO of Kardigan?

Tassos Gianakakos is listed as CEO at Kardigan.

Where is Kardigan headquartered?

Kardigan is based in South San Francisco, California, United States.

How many employees does Kardigan have?

Kardigan is in the 51-100 employee band.

How does Kardigan's funding compare to other Biotechnology startups?

Kardigan's latest round of $254M is above the $8.4M median round size for Biotechnology companies on FundedIQ across 4,185 tracked companies over the last two years.

About FundedIQ's Kardigan Funding Data

FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.

Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Kardigan is left off this page rather than filled in.

14-day free trial · Cancel anytime

Know who just raised. Then know who to reach.

Startup funding intelligence on every funded startup: the round, the investors and the founders, as a file in your inbox or searchable in the app.

Radar from $49/mo · Pro from $149/mo. Card required, nothing charged until day 15, and we email you 3 days before that. Need something specific? Custom plans from $499/mo.